DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.65, $0.45 better than the analyst estimate of $0.20. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE